血中滞留性リポソーム封入ドキソルビシンの腹腔癌における抗腫瘍効果制御システムの構築

Saved in:
Bibliographic Details
Published inDrug Delivery System Vol. 14; no. 2; pp. 109 - 113
Main Authors 原島, 秀吉, 土橋, 麻理, 際田, 弘志
Format Journal Article
LanguageJapanese
Published 日本DDS学会 10.03.1999
Online AccessGet full text
ISSN0913-5006
1881-2732
DOI10.2745/dds.14.109

Cover

Author 原島, 秀吉
土橋, 麻理
際田, 弘志
Author_xml – sequence: 1
  fullname: 原島, 秀吉
  organization: 徳島大学薬学部
– sequence: 1
  fullname: 土橋, 麻理
  organization: 徳島大学薬学部
– sequence: 1
  fullname: 際田, 弘志
  organization: 徳島大学薬学部
BookMark eNo9kEtLw0AAhBepYFu9-D9Sd7NpNzlK8QUFL72HzSbRhlol8SJemoSIbfUgKlrQYg9SsFQFQS0-_syax88wavEyAzN8c5gcyDS2GwYA8wgWRCIVF3TdKSCpgKAyBbJIlpEgEixmQBYqCAtFCEszIOc4FoRSWqIs2E_6za_XUfTWi8-7UXPA_TvuX3Pvg_vv3L8JH90wuOV-i3uj33DI_VPuvXD_ibv3STBOgrO4e8TdIXfb3D3hXidqXyTBML48DtvjqHcVHj6Hn_0fxBtz_yDdTMFo0IkfWrNg2qR1x5ibeB5Ul5eq5VWhsr6yVl6sCJYsUUEzcYnoSFcIZFDDRINMERGTRVNkRBYJQbBIENNlamKmmwbDDCNDpxplhpGyOA_Kf7OWs0s3DHXHrm1Re0-l9m6N1Q01_QwpcklFkipOBCr_LduktmpR_A1nfpY6
ContentType Journal Article
Copyright 日本DDS学会
Copyright_xml – notice: 日本DDS学会
DOI 10.2745/dds.14.109
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1881-2732
EndPage 113
ExternalDocumentID article_dds1986_14_2_14_2_109_article_char_ja
GroupedDBID .55
3O-
53G
5GY
ACIWK
ACPRK
AFRAH
ALMA_UNASSIGNED_HOLDINGS
CS3
JSF
JSH
OK1
RJT
RZJ
X7M
ID FETCH-LOGICAL-j84a-bf367d1d970c0b37b0c921c82f2c7827710571cd8af3cdfec3c31edabaceef363
ISSN 0913-5006
IngestDate Wed Sep 03 06:29:50 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 2
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j84a-bf367d1d970c0b37b0c921c82f2c7827710571cd8af3cdfec3c31edabaceef363
OpenAccessLink https://www.jstage.jst.go.jp/article/dds1986/14/2/14_2_109/_article/-char/ja
PageCount 5
ParticipantIDs jstage_primary_article_dds1986_14_2_14_2_109_article_char_ja
PublicationCentury 1900
PublicationDate 1999/03/10
PublicationDateYYYYMMDD 1999-03-10
PublicationDate_xml – month: 03
  year: 1999
  text: 1999/03/10
  day: 10
PublicationDecade 1990
PublicationTitle Drug Delivery System
PublicationTitleAlternate DDS
PublicationYear 1999
Publisher 日本DDS学会
Publisher_xml – name: 日本DDS学会
References 7) Bally MB, Masin D, Nayar R, Cullis PR, Mayer LD : Transfer of liposomal drug carriers from the blood to the peritoneal cavity of nomal and ascitic tumor-bearing mice. Cancer Chemother. Pharmacol. 34 : 137-146, 1994.
10) Ozawa S, Sugiyama T, Mitsuhashi Y, Kobayashi T, Inaba M : Cell killing action of cell cycle phase-nonspecific antitumor agents is dependent on concentration-time products. Cancer Chemother. Pharmacol. 21 : 185-190, 1988.
17) Druckman S, Gabizon A, Batenholz Y : Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma : Implication for pharmacokinetic studies. Biochemica et Biophysica Acta 980 : 381-384, 1989.
11) Mayhew E, Cimino M, Klemperer J, Lazo R, Wiernikowaki J, Arbuck S : Free and liposormal doxorubicin trearment of intraperitoneal colon 26 tumor : Therapeutic and pharmacologic studies. Selective Cancer Therapeutic 6(4) : 193-209, 1990.
18) Chonn A, Semple S, Cullis PR : Separation of large unilamellar liposomes from blood components by a spin column procedure : towards identifying plasma proteins which mediate liposome clearance in vivo. Biochemica et Biophysica Acta 1070 : 215-222, 1991.
14) Boman NL, Mayer LD, Cullis PR : Optimization of the retention properties of vincristine in liposomel systems. Biochemica et Biophysica Acta 1152 : 253-258, 1993.
9) Huang SK, Lee KD, Hong K, Friend DS, Papahadjopoulos D : Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res. 52 : 5135-5143, 1992.
13) Mayer LD, Nayar R, Thies RL, Boman NL, Cullis PR, Bally MB : Identification of vesicle properties that enhance the antitumour activity of liposormal vincristine against muline L1210 leukemia. Cancer Chemother. Pharmacol. 33 : 17-24, 1993.
8) Ozawa S, Sugiyama Y, Mitsuhashi J, Inaba M : Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and chinese hamster cells. Cancer Res. 49 : 3823-3828, 1989.
19) Bachur NR, Moore AL, Bernstein JG, Liu A : Tissue distribution and disposition of daunomycin (NSC-82151) in mice : Fluorometric and isotopic methods. Cancer Chemother. Rep. 54 : 89-94, 1970.
6) Harashima H, Iida S, Urakami Y, Tsuchihashi M, Kiwada H : Optimization of antitumor effect of liposomaly encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling. (submitted for publication).
16) Mayer LD, Tai LCL, Bally MB, Mitilenes GN, Ginsberg RS, Cullis PR : Characterization of tiposomai systems containing doxorubicin entrapped in response to pH gradients. Biochemica et Biophysics Acta 1025 : 143-151, 1990.
2) Gabizon A, Shiota R, Papahadjopoulos D : Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J. Natl. Cancer Inst. 81 : 1484-1488, 1989.
4) Huang SK, Mayhew E, Gilani S, Lasic DD, Martin FJ, Papahadjopoulos D : Pharmacokinetics and therapeutic of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res. 52 : 6774-6781, 1992.
5) Urakami Y, Harashima H, Iida S, Nagayasu A, Kiwada H : Kinetic study on the optimization of tumor delivery of antitumor agents by liposomes : Simulation study based on the physiological modeling. DDS 12(6) : 101-106, 1997.
15) Horowitz AT, Barenholz Y, Gabizon A : In vitro cytotoxicity of liposome-encapsulated doxorubicin : dependence on liposome composition and drug release. Biochemica et Biophysics Acta 1109 : 203-209, 1992.
1) Mayer LD, Tai LCL, Ko DSC, Masin D, Ginsberg RS et al. : Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. 49 : 5922-5930, 1989.
12) Inaba M, Johnson RK : Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant subline of P388 leukemia. Bio. Pharm. 27 : 2123-2130, 1978.
3) Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K et al. : Sterically stabilized liposomes : Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA 88 : 11460-11464, 1991.
References_xml – reference: 16) Mayer LD, Tai LCL, Bally MB, Mitilenes GN, Ginsberg RS, Cullis PR : Characterization of tiposomai systems containing doxorubicin entrapped in response to pH gradients. Biochemica et Biophysics Acta 1025 : 143-151, 1990.
– reference: 7) Bally MB, Masin D, Nayar R, Cullis PR, Mayer LD : Transfer of liposomal drug carriers from the blood to the peritoneal cavity of nomal and ascitic tumor-bearing mice. Cancer Chemother. Pharmacol. 34 : 137-146, 1994.
– reference: 11) Mayhew E, Cimino M, Klemperer J, Lazo R, Wiernikowaki J, Arbuck S : Free and liposormal doxorubicin trearment of intraperitoneal colon 26 tumor : Therapeutic and pharmacologic studies. Selective Cancer Therapeutic 6(4) : 193-209, 1990.
– reference: 19) Bachur NR, Moore AL, Bernstein JG, Liu A : Tissue distribution and disposition of daunomycin (NSC-82151) in mice : Fluorometric and isotopic methods. Cancer Chemother. Rep. 54 : 89-94, 1970.
– reference: 4) Huang SK, Mayhew E, Gilani S, Lasic DD, Martin FJ, Papahadjopoulos D : Pharmacokinetics and therapeutic of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res. 52 : 6774-6781, 1992.
– reference: 17) Druckman S, Gabizon A, Batenholz Y : Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma : Implication for pharmacokinetic studies. Biochemica et Biophysica Acta 980 : 381-384, 1989.
– reference: 10) Ozawa S, Sugiyama T, Mitsuhashi Y, Kobayashi T, Inaba M : Cell killing action of cell cycle phase-nonspecific antitumor agents is dependent on concentration-time products. Cancer Chemother. Pharmacol. 21 : 185-190, 1988.
– reference: 14) Boman NL, Mayer LD, Cullis PR : Optimization of the retention properties of vincristine in liposomel systems. Biochemica et Biophysica Acta 1152 : 253-258, 1993.
– reference: 12) Inaba M, Johnson RK : Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant subline of P388 leukemia. Bio. Pharm. 27 : 2123-2130, 1978.
– reference: 3) Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K et al. : Sterically stabilized liposomes : Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA 88 : 11460-11464, 1991.
– reference: 6) Harashima H, Iida S, Urakami Y, Tsuchihashi M, Kiwada H : Optimization of antitumor effect of liposomaly encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling. (submitted for publication).
– reference: 18) Chonn A, Semple S, Cullis PR : Separation of large unilamellar liposomes from blood components by a spin column procedure : towards identifying plasma proteins which mediate liposome clearance in vivo. Biochemica et Biophysica Acta 1070 : 215-222, 1991.
– reference: 2) Gabizon A, Shiota R, Papahadjopoulos D : Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J. Natl. Cancer Inst. 81 : 1484-1488, 1989.
– reference: 1) Mayer LD, Tai LCL, Ko DSC, Masin D, Ginsberg RS et al. : Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. 49 : 5922-5930, 1989.
– reference: 5) Urakami Y, Harashima H, Iida S, Nagayasu A, Kiwada H : Kinetic study on the optimization of tumor delivery of antitumor agents by liposomes : Simulation study based on the physiological modeling. DDS 12(6) : 101-106, 1997.
– reference: 13) Mayer LD, Nayar R, Thies RL, Boman NL, Cullis PR, Bally MB : Identification of vesicle properties that enhance the antitumour activity of liposormal vincristine against muline L1210 leukemia. Cancer Chemother. Pharmacol. 33 : 17-24, 1993.
– reference: 9) Huang SK, Lee KD, Hong K, Friend DS, Papahadjopoulos D : Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res. 52 : 5135-5143, 1992.
– reference: 8) Ozawa S, Sugiyama Y, Mitsuhashi J, Inaba M : Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and chinese hamster cells. Cancer Res. 49 : 3823-3828, 1989.
– reference: 15) Horowitz AT, Barenholz Y, Gabizon A : In vitro cytotoxicity of liposome-encapsulated doxorubicin : dependence on liposome composition and drug release. Biochemica et Biophysics Acta 1109 : 203-209, 1992.
SSID ssj0048811
ssib058492641
ssib007483962
ssib001535732
ssib002484529
Score 1.488868
SourceID jstage
SourceType Publisher
StartPage 109
Title 血中滞留性リポソーム封入ドキソルビシンの腹腔癌における抗腫瘍効果制御システムの構築
URI https://www.jstage.jst.go.jp/article/dds1986/14/2/14_2_109/_article/-char/ja
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Drug Delivery System, 1999/03/10, Vol.14(2), pp.109-113
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3LbtNA0CrlwgXxFG_lwPZUF9vrx67EZZ04qkCgIoLUW-RHghShgvo4FC5NrCDawgEBgkpQ0QOqRFVAQgIqHj9jkvQLODO7XicucKBwsSa7M7OzM2vvrDMzVpSzJk_L9bVQ1Wk9VE3bN1ViYKw6BAeBboRUN3i-86XL9vg188KkNTm050cuamluNhgLb_8xr-RfrAptYFeeJbsLy_aZQgPAYF-4goXh-lc2Rh5BTOfBCp6JXIBLyLOR6yLqIc9B1EKU8hZAYA7yMCIYMSYBWhKAgdySbHGLGQ4wtJCrgZvJAWIhZskuQiUV-42cuRlnnHVlg7ppi46Yx2UGhi6VADWFqBSRYobjSoAwCVBdMiSumA5D1JHkHBnIAS4JUZngbHMN0KJoIci1xXQ8rqsdghkCOZ2XnZt7X1Sb642IIVgZpV8hylz50vTcdXhc3-CBLfOy8nu2fMXAIEFZDIy5BLCUBRtHmAvmrWX8JD6Iy_FhSMqHFPgUuYzbk08R8O0BPkUUtJD2mNxUAt_iNgRlcKCM0pDk9J1OWgeCBwj270KhJkeY1uajs2KpdJWTgmmZLZYUMGP5l7k6Vi1Nk0XF062MEJ0nXu3c68zcPW3kNi5dozkfSE_zg3_dXg3H5JVIomgGNtixPsmOcuXyZqgCkk6JDUfLqiEvGq1mvTylsNqAc81ew3FEeMXFK_l_b7Hl5MvqmYTHB_R_Oya49YMyl-BDU_Dr-6FdsCeJ7273tZKWJebSnxvIDi5nAw5gWfCm8CcrB5T98iBYYKmoB5Whhn9IGZlIK8nPjxYqg8TImdHCSGFiUGN-_rByZ3tt4funze7n1d6Tle7CehK_TuIXSetrEn9J4pedd81O-1USLyatTdG4kcSPktbHJH6fNN9st7e22497K_eT5kbSXEqaD5PWcnfp6XZ7o_fsQWdpq7v6vHPvQ-fbGidpbSXxXeAJhN315d7bxSNKpexViuOq_I6K2iCmrwZ1bDuRHlFHC7UAO4EWUkMPiVE3QjgfgP7hzKaHEfHrOIzqtRCHWK9FfuCDAw20-KgyPHVzqnZMKfjgEBAfnu5WBJ5_jfrg3QaYmgENQivEtePK-VSn1VtprZzqrpbDif8jP6nsG9xMp5Th2em52mk4MswGZ8T6-gkCbPft
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%A1%80%E4%B8%AD%E6%BB%9E%E7%95%99%E6%80%A7%E3%83%AA%E3%83%9D%E3%82%BD%E3%83%BC%E3%83%A0%E5%B0%81%E5%85%A5%E3%83%89%E3%82%AD%E3%82%BD%E3%83%AB%E3%83%93%E3%82%B7%E3%83%B3%E3%81%AE%E8%85%B9%E8%85%94%E7%99%8C%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E6%8A%97%E8%85%AB%E7%98%8D%E5%8A%B9%E6%9E%9C%E5%88%B6%E5%BE%A1%E3%82%B7%E3%82%B9%E3%83%86%E3%83%A0%E3%81%AE%E6%A7%8B%E7%AF%89&rft.jtitle=Drug+Delivery+System&rft.au=%E5%8E%9F%E5%B3%B6%2C+%E7%A7%80%E5%90%89&rft.au=%E5%9C%9F%E6%A9%8B%2C+%E9%BA%BB%E7%90%86&rft.au=%E9%9A%9B%E7%94%B0%2C+%E5%BC%98%E5%BF%97&rft.date=1999-03-10&rft.pub=%E6%97%A5%E6%9C%ACDDS%E5%AD%A6%E4%BC%9A&rft.issn=0913-5006&rft.eissn=1881-2732&rft.volume=14&rft.issue=2&rft.spage=109&rft.epage=113&rft_id=info:doi/10.2745%2Fdds.14.109&rft.externalDocID=article_dds1986_14_2_14_2_109_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0913-5006&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0913-5006&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0913-5006&client=summon